271 related articles for article (PubMed ID: 25690650)
1. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.
Smith HK; Gil CD; Oliani SM; Gavins FN
FASEB J; 2015 May; 29(5):2161-71. PubMed ID: 25690650
[TBL] [Abstract][Full Text] [Related]
2. Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
Vital SA; Becker F; Holloway PM; Russell J; Perretti M; Granger DN; Gavins FN
Circulation; 2016 May; 133(22):2169-79. PubMed ID: 27154726
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
[TBL] [Abstract][Full Text] [Related]
4. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.
Gavins FN; Hughes EL; Buss NA; Holloway PM; Getting SJ; Buckingham JC
FASEB J; 2012 Dec; 26(12):4977-89. PubMed ID: 22964301
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets.
Zharkova O; Salamah MF; Babak MV; Rajan E; Lim LHK; Andrade F; Gil CD; Oliani SM; Moraes LA; Vaiyapuri S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834844
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
[TBL] [Abstract][Full Text] [Related]
8. Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A
Hughes EL; Becker F; Flower RJ; Buckingham JC; Gavins FNE
Br J Pharmacol; 2017 Jul; 174(14):2393-2408. PubMed ID: 28471519
[TBL] [Abstract][Full Text] [Related]
9. Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.
Ansari J; Senchenkova EY; Vital SA; Al-Yafeai Z; Kaur G; Sparkenbaugh EM; Orr AW; Pawlinski R; Hebbel RP; Granger DN; Kubes P; Gavins FNE
Blood; 2021 Mar; 137(11):1538-1549. PubMed ID: 33512489
[TBL] [Abstract][Full Text] [Related]
10. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.
Brancaleone V; Gobbetti T; Cenac N; le Faouder P; Colom B; Flower RJ; Vergnolle N; Nourshargh S; Perretti M
Blood; 2013 Jul; 122(4):608-17. PubMed ID: 23733341
[TBL] [Abstract][Full Text] [Related]
11. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
12. The G-Protein-Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands.
Wang CS; Baker OJ
Am J Pathol; 2018 Jul; 188(7):1555-1562. PubMed ID: 29684359
[TBL] [Abstract][Full Text] [Related]
13. Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.
Vital SA; Senchenkova EY; Ansari J; Gavins FNE
Cells; 2020 Nov; 9(11):. PubMed ID: 33202930
[TBL] [Abstract][Full Text] [Related]
14. Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis.
Zhu X; Peng X; Lin J; Zhang Y; He H; Zhao G
Int Immunopharmacol; 2021 Jul; 96():107785. PubMed ID: 34162149
[TBL] [Abstract][Full Text] [Related]
15. Electroacupuncture decreases inflammatory pain through a pro-resolving mechanism involving the peripheral annexin A1-formyl peptide receptor 2/ALX-opioid receptor pathway.
Vieira C; Salm DC; Horewicz VV; Ludtke DD; Emer AA; Koerich JF; Mazzardo G; Elias S; Moré AOO; Mazzardo-Martins L; Cidral-Filho FJ; Reed WR; Piovezan AP; Martins DF
Pflugers Arch; 2021 Apr; 473(4):683-695. PubMed ID: 33474635
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
17. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
[TBL] [Abstract][Full Text] [Related]
18. Hydroalcoholic crude extract of Casearia sylvestris Sw. reduces chronic post-ischemic pain by activation of pro-resolving pathways.
Piovezan AP; Batisti AP; Benevides MLACS; Turnes BL; Martins DF; Kanis L; Duarte ECW; Cavalheiro AJ; Bueno PCP; Seed MP; Norling LV; Cooper D; Headland S; Souza PRPS; Perretti M
J Ethnopharmacol; 2017 May; 204():179-188. PubMed ID: 28412216
[TBL] [Abstract][Full Text] [Related]
19. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct.
Gavins FN; Kamal AM; D'Amico M; Oliani SM; Perretti M
FASEB J; 2005 Jan; 19(1):100-2. PubMed ID: 15507472
[TBL] [Abstract][Full Text] [Related]
20. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
